Comparative efficacy and safety of glucagon-like peptide 1 receptor agonists for the treatment of type 2 diabetes: A network meta-analysis.

Han ChenXin-Zhu LiJia-Qing ChenTian-Shu RenYing-Shi ZhangYi-Nuo WangQing-Chun Zhao

Published in: Medicine (2023)

Regimens of GLP-1RAs had differential glycemic control. The efficacy and safety of Semaglutide 2.0mg in comprehensively lowering blood sugar showed the best performance.

Keyphrases

glycemic control
type diabetes
blood glucose
weight loss
insulin resistance
combination therapy
replacement therapy
wild type